阿里雲再次中標國家醫保局雲平台
內地傳媒報道,阿里巴巴(09988.HK)旗下阿里雲中標國家醫療保障局核心業務區雲平台資源擴容項目,據中標公告顯示,該項目預算金額2,000萬元人民幣(下同),中標金額1,966萬元。
據稱,阿里雲平台符合《醫療保障信息平台雲計算平台規範》中的技術標準;現時國家醫保信息平台與阿里雲的系統適配驗證、應用安裝部署、數據庫訪問性能、雲平台容災演練等全方位落地測試驗證已全部完成。全國統一的醫保信息平台有望於今年底前投入使用。據悉,目前全國已招標省份的醫保平台,大多選擇阿里雲承擔核心業務區的建設。(ka/w)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.